Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Genentech’s Ocrevus for relapsing and primary progressive forms of MS

cphi-onlineMarch 30, 2017

Tag: Genentech

PharmaSources Customer Service